Apparently researchers are closing in on a cure for smoking. Or rather there are a number of companies developing tools to combat the ‘disease’. From the ‘believe it when you see it dept’.
Then there’s NicVax, a drug that Florida-based Nabi Pharmaceuticals claims could be used as a nicotine vaccine. NicVax triggers the production of antibodies that bind to nicotine molecules, preventing them from reacting with receptors in the brain. NicVax, which was developed primarily with grants from the National Institute on Drug Abuse, has shown promise in early trials and could begin Phase III testing late this year, the company said.